Immunomics: From Molecular Studies to Preclinical Trials

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Bioinformatics and Systems Biology".

Deadline for manuscript submissions: 15 May 2024 | Viewed by 226

Special Issue Editors

Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria
Interests: plastic surgery; microsurgery; immunology
Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria
Interests: genetics; genomics; epigenetics; chromatin; metabolomics; proteomics; immunology

Special Issue Information

Dear Colleagues,

Integrating cutting-edge research data into clinical decisions can lead to the identification of complex and unique molecular features.

The use of genomic and proteomic technologies to study immune system regulation and response to pathogens allows scientists a visualization of biological networks and gene and/or protein interactions to help better understand how the immune system functions and how it is regulated.

The focus of this Special Issue of Biomolecules will be on the most recent advances related to the exploitation of genome/proteome and metabolome-wide studies and matched targeted therapy/immunotherapy deployment in patients. Recent advances in the development, refinement, and discovery of individual genes and molecules, high-throughput, high-resolution omics technologies combined with sophisticated computational modeling and machine-learning approaches in clinical trials will be addressed.

Discussion on using human patient samples, the synchronization of the scientific process in the clinical routine and presentation of novel approaches to complement standard immunological methods with new insights into immune-system dynamics, along with the integration of OMICS analyses in precision medicine, will be encouraged in this context.

Finally, an overview of recent rapid biotechnological breakthroughs; genomic profiling; and transcriptomic, immunomic, and proteomic interrogations that have led to the identification of complex and unique molecular features and therapy optimization in this field will be included.

Research and review articles presenting novelties or overviews, respectively, are welcome.

Dr. Dolores Wolfram
Dr. Ines Schoberleitner
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunomics
  • immunology
  • inflammation
  • genomics
  • transcriptomics
  • proteomics
  • metabolomics
  • immunome
  • immunoprofile
  • immunophenotype
  • vaccines
  • vaccine design
  • vaccine development regulatory networks
  • antigen discovery
  • complex pathogens

Published Papers

This special issue is now open for submission.
Back to TopTop